Patents Assigned to Sederma S.A.S.
  • Patent number: 10758473
    Abstract: According to the present invention, an extract is obtained from the Globularia genus is obtained from a plant of the genus Globularia and is used for a non-therapeutic cosmetic treatment of the skin and/or appendages. Preferably the species is Globularia cordifolia and the extract is obtained by in vitro plant culture. The extract can be used for preventing and/or treating skin ageing by stimulating the reactions of detoxification and cellular regeneration through a hormetic type response, for improving the transparency and radiance of complexion, for preventing or treating sensitive and reactive skins, for preventing or treating rednesses, for preventing protein glycation, for increasing and/or maintaining the number of dermal stem cells, for increasing and/or maintaining the dermal macromolecules, in particular collagen and elastin, for increasing the volume of the dermis, for preventing and/or treating fines lines and wrinkles, for firming skin, for preventing hair loss and/or stimulating hair regrowth.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: September 1, 2020
    Assignee: Sederma, S.A.S.
    Inventors: Arnaud Fournial, Claire-Marie Grizaud, Philippe Mondon, Caroline Le Moigne
  • Patent number: 10159636
    Abstract: The present invention relates to the field of cosmetic and dermopharmaceutical compositions. It concerns oligomer compounds of D-glucuronic acid or D-glucuronate with a ? (1-4) sequence (or oligoglucuronans) containing a degree of acetylation specifically between 8.7±0.5 and 9.2±0.5% by weight of O—CO—CH3 group compared to the weight of glucuronic acid and with a degree of polymerisation (DP) of 18-19±2. The oligomer compounds according to the present invention are intended to stimulate the elasticity of the dermis and epidermis although they also act to increase dermo-epidermal cohesion in order to combat skin ageing, lines, wrinkles, visible and/or tactile skin discontinuities, loss of firmness, elasticity and tone and to combat skin tissue deformability. The invention also concerns a cosmetic composition containing at least one compound as recited according to the present invention.
    Type: Grant
    Filed: March 23, 2015
    Date of Patent: December 25, 2018
    Assignee: Sederma, S.A.S.
    Inventors: Arnaud Fournial, Claire-Marie Grizaud, Caroline Le Moigne, Philippe Mondon
  • Patent number: 9925135
    Abstract: According to the present invention the extract of plant origin of the Globularia genus is used for a non-therapeutic cosmetic treatment of the skin and/or appendages. Preferably the species is Globularia cordifolia and the extract is obtained by in vitro plant culture. The extract can be used in particular for preventing and/or treating skin ageing by stimulating the 10 reactions of detoxification and cellular regeneration through a hormetic type response, for improving the transparency and radiance of complexion, for preventing or treating sensitive and reactive skins, for preventing or treating rednesses, for preventing protein glycation, for increasing and/or maintaining the number of dermal stem cells, for increasing and/or maintaining the dermal macromolecules, in particular collagen and elastin, for increasing the volume of the dermis, for 15 preventing and/or treating fines lines and wrinkles, for firming skin, for preventing hair loss and/or stimulating hair regrowth.
    Type: Grant
    Filed: January 30, 2012
    Date of Patent: March 27, 2018
    Assignee: Sederma, S.A.S.
    Inventors: Arnaud Fournial, Claire-Marie Grizaud, Philippe Mondon, Caroline Le Moigne
  • Patent number: 8603498
    Abstract: The compound according to the invention has the following developed formula IX: wherein: X=PO(OH)2; SO2(OH); PO(OH)(Xaa)m or SO2(Xaa)m; A=H; OH; NH2 or akyl (1-6C); n=1 to 4; Y=—CO—OR2; —CO—NR3R4; —O—CO—R2; —C?CR2; R2=an alkyl, aryl, aralkyl, acyl, sulfonyl, sugar or alkoxy chain of 1 to 24 carbon atoms, linear, branched or cyclic, with or without substitutions, saturated or not, hydroxylated or not, sulfurated or not; R5=OH, O-alk (1-6C), (Xaa)m, NH2 or NH-alkyl(1-6C); Xaa=peptide of m aminoacids Xaa with m from 1 to 10; The compound is preferably phosphated, obtained from malic acid and having the following developed formula: A cosmetic composition comprising the compound of the present invention can improve the general condition of the skin, for example hydration, lightening and mechanical properties.
    Type: Grant
    Filed: January 17, 2011
    Date of Patent: December 10, 2013
    Assignee: Sederma, S.A.S.
    Inventors: Arnaud Fournial, Philippe Mondon, Olivier Peschard
  • Publication number: 20130309332
    Abstract: According to the present invention the extract of plant origin of the Globularia genus is used for a non-therapeutic cosmetic treatment of the skin and/or appendages. Preferably the species is Globularia cordifolia and the extract is obtained by in vitro plant culture. The extract can be used in particular for preventing and/or treating skin ageing by stimulating the 10 reactions of detoxification and cellular regeneration through a hormetic type response, for improving the transparency and radiance of complexion, for preventing or treating sensitive and reactive skins, for preventing or treating rednesses, for preventing protein glycation, for increasing and/or maintaining the number of dermal stem cells, for increasing and/or maintaining the dermal macromolecules, in particular collagen and elastin, for increasing the volume of the dermis, for 15 preventing and/or treating fines lines and wrinkles, for firming skin, for preventing hair loss and/or stimulating hair regrowth.
    Type: Application
    Filed: January 30, 2012
    Publication date: November 21, 2013
    Applicant: SEDERMA, S.A.S.
    Inventors: Arnaud Fournial, Claire-Marie Grizaud, Philippe Mondon, Caroline Le Moigne
  • Patent number: 8388939
    Abstract: The subject matter of the present invention is a cosmetic or dermopharmaceutic composition comprising a combination of homarine and erythritol as well as a non-therapeutic treatment method of the skin to improve cutaneous hydration, to prevent and/or treat cutaneous dryness signs, to restore and/or protect the cutaneous barrier function, to protect cells of the skin and/or of the scalp from osmotic shocks, for example from UV induced osmotic shocks.
    Type: Grant
    Filed: February 13, 2009
    Date of Patent: March 5, 2013
    Assignee: Sederma, S.A.S.
    Inventors: Arnaud Fournial, Claire Mas-Chamberlin, Philippe Mondon, Olivier Peschard
  • Patent number: 8377663
    Abstract: The present invention relates to cosmetic compositions comprising an association of hydroxymethionine and 3-aminopropanesulfonic acid, and a cosmetic method for the skin. These compositions are intended to prevent and/or treat the signs of the cutaneous ageing such as the sagging of the cutaneous and subcutaneous tissue, the loss of cutaneous elasticity and atony of the texture of the skin, the loss of firmness and tonicity, dermal atrophy and loss of density, wrinkle, little wrinkle, crack.
    Type: Grant
    Filed: September 11, 2008
    Date of Patent: February 19, 2013
    Assignee: Sederma, S.A.S.
    Inventors: Karl Lintner, Claire Mas Chamberlin
  • Publication number: 20130004439
    Abstract: The compound according to the invention has the following developed formula IX: wherein: X=PO(OH)2; SO2(OH); PO(OH)(Xaa)m or SO2(Xaa)m; A=H; OH; NH2 or akyl (1-6C); n=1 to 4; Y=—CO—OR2; —CO—NR3R4; —O—CO—R2; —C?CR2; R2=an alkyl, aryl, aralkyl, acyl, sulfonyl, sugar or alkoxy chain of 1 to 24 carbon atoms, linear, branched or cyclic, with or without substitutions, saturated or not, hydroxylated or not, sulfurated or not; R5=OH, O-alk (1-6C), (Xaa)m, NH2 or NH-alkyl(1-6C); Xaa=peptide of m aminoacids Xaa with m from 1 to 10; The compound is preferably phosphated, obtained from malic acid and having the following developed formula: A cosmetic composition comprising the compound of the present invention can improve the general condition of the skin, for example hydration, lightening and mechanical properties.
    Type: Application
    Filed: January 17, 2011
    Publication date: January 3, 2013
    Applicant: Sederma, S.A.S.
    Inventors: Arnaud Fournial, Philippe Mondon, Olivier Peschard
  • Publication number: 20110250276
    Abstract: The present invention relates to the field of cosmetic and dermopharmaceutical compositions. It concerns oligomer compounds of D-glucuronic acid or D-glucuronate with a ? (1-4) sequence (or oligoglucuronans) containing a degree of acetylation specifically between 8.7±0.5 and 9.2±0.5% by weight of O—CO—CH3 group compared to the weight of glucuronic acid and with a degree of polymerisation (DP) of 18?19±2. The oligomer compounds according to the present invention are intended to stimulate the elasticity of the dermis and epidermis although they also act to increase derma-epidermal cohesion in order to combat skin ageing, lines, wrinkles, visible and/or tactile skin discontinuities, loss of firmness, elasticity and tone and to combat skin tissue deformability. The invention also concerns a cosmetic composition containing at least one compound as recited according to the present invention.
    Type: Application
    Filed: December 10, 2009
    Publication date: October 13, 2011
    Applicant: Sederma, S.A.S.
    Inventors: Arnaud Fournial, Claire-Marie Grizaud, Caroline Le Moigne, Philippe Mondon
  • Publication number: 20110092821
    Abstract: The invention relates to a device for measuring the mechanical properties of the skin which is free from all parameters interfering with measurement. The device comprises: a) a pneumatic assembly (16) for delivering compressed air to apply a stress to the surface of the skin undergoing measurement, b) an electronic assembly (6) for contact-free measurements on said surface of the skin subjected to the stress, and c) a control software (19) for controlling the electronic assembly (6) and for processing measurement data in order to deduce the mechanical properties of the skin.
    Type: Application
    Filed: May 29, 2009
    Publication date: April 21, 2011
    Applicant: SEDERMA S.A.S.
    Inventors: Arnaud Fournial, Philippe Mondon, Sébastien Fache, Claire Mas Chamberlin
  • Publication number: 20110002865
    Abstract: The subject matter of the present invention is a cosmetic or dermopharmaceutic composition comprising a combination of homarine and erythritol as well as a non-therapeutic treatment method of the skin to improve cutaneous hydration, to prevent and/or treat cutaneous dryness signs, to restore and/or protect the cutaneous barrier function, to protect cells of the skin and/or of the scalp from osmotic shocks, for example from UV induced osmotic shocks.
    Type: Application
    Filed: February 13, 2009
    Publication date: January 6, 2011
    Applicant: SEDERMA, S.A.S.
    Inventors: Arnaud Fournial, Claire Mas-Chamberlin, Philippe Mondon, Olivier Peschard
  • Patent number: 6974799
    Abstract: Pharmaceutical, personal care and cosmetic compositions containing a tripeptide and a tetrapeptide are useful for treating visible signs of aging including wrinkles, stretch marks and dark circles.
    Type: Grant
    Filed: December 10, 2003
    Date of Patent: December 13, 2005
    Assignee: Sederma S.A.S.
    Inventor: Karl Lintner
  • Publication number: 20040132667
    Abstract: Pharmaceutical, personal care and cosmetic compositions containing a tripeptide and a tetrapeptide are useful for treating visible signs of aging including wrinkles, stretch marks and dark circles.
    Type: Application
    Filed: December 10, 2003
    Publication date: July 8, 2004
    Applicant: SEDERMA S.A.S
    Inventor: Karl Lintner
  • Publication number: 20040120918
    Abstract: Personal care products including cosmetics, grooming products and topical pharmaceutical products can be produced including a polypeptide of between 3 and 12 amino acids in length and a ceramide. These formulations are particularly useful in addressing wrinkles in human subjects and in particular facial skin and hands. Certain analogs and derivatives of these polypeptides may be used in these formulations and/or alone. Methods of using these formulations are also disclosed.
    Type: Application
    Filed: December 19, 2003
    Publication date: June 24, 2004
    Applicant: SEDERMA S.A.S.
    Inventors: Karl Lintner, Denise E. Gabriele